When Worlds Collide: The Theory of Real-World Evidence Meets Reality
FDA Law Blog: Biosimilars
MAY 13, 2024
FDA has even gone so far as to maintain that the “real-life clinical performance of a medical product might be more clearly demonstrated through RWD/RWE because a controlled clinical trial often cannot evaluate all applications of a product in clinical practice across the full range of potential users.”
Let's personalize your content